We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Study of Eisai treatment will be one of last chances to prove amyloid hypothesis, say experts
Tofersen targets a defective gene that causes about 2% of cases of MND, also known as amyotrophic lateral sclerosis
Newly listed consumer health group refuses indemnification requests related to heartburn drug
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Chief US medical adviser says anti-vax attitudes could spill over and cause disease outbreaks
Ashish Jha says vaccines and drugs will be limited if Congress fails to approve further funding
Some health experts say vaccination campaign risks undermining public trust
New techniques to prevent and treat tumours could be developed after researchers identify role played by inflammation
Technology used to develop Covid vaccines may help in the fight against other diseases
Booster yielded efficacy as high as 80% in one group, Lancet study shows
US biotech to object to impending EU ruling on $8bn deal for cancer screening group
Pharmaceutical companies have taken aim at group whose research helped spark a wave of lawsuits
Setback for FTC after administrative law judge gives nod to acquisition of cancer testing group
Venture capitalists have put $236mn into mind-expanding treatment research in the 12 months to July
Drugmaker sued its former head of investor relations over alleged breach of a non-compete clause
FDA clears jabs despite lack of human trials in effort to curb winter wave of Covid infections
Therapeutic research initiative aims to raise $1bn after receiving largest single donation in Australian medical history
Treatment is new weapon against mosquito-borne disease that kills 20,000 people a year
Having helped create the AstraZeneca Covid-19 drug, the Oxford scientist has another urgent goal, to eliminate malaria through vaccination
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs developed to combat the pandemic
Covid exposed Africa’s dependence on overseas production but local initiatives show potential
Swiss group takes bold step to focus on faster-growing and higher-margin medicines
US pharma group says RSV vaccine is 86% effective at preventing severe disease
Danish manufacturer of only approved shot against disease seeks to expand manufacturing capacity
Vaccine targeting BA.4/BA.5 could become first shot to win green light without human trials
International Edition
